FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/19/2023
Back to search
Official data from USPTO
MOLECULE.ONE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
04/19/2023
Trademark type
Combined
Nice classes
9, 42
Filing date
09/02/2019
Registration date
11/15/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/15/2022
Last transaction
11/15/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
PL
Examiner
XU, ELAINE YILIN
Law office
N90
Current location
TMO LAW OFFICE 127
Mark description
The mark consists of a concentric design comprised of two circles, one within the other, made up of dots. The dots in the outer circle are larger than those in the inner circle, with one stand alone dot to the upper right of the concentric design followed by the words "Molecule.one".
Holders and representatives
Holders
M. O. (pessoa física)
Representatives
Peter J. Rosene McBrayer PLLC
Technical classification
Nice Classes
Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer software for use in data analysis in the field of medicine; Downloadable Computer software for use in systems to support medical decision-making; Humanoid robots with artificial intelligence; Downloadable Software based on artificial intelligence technology for use in designing synthesis paths; Downloadable Computer software for use in data analysis capable of understanding and analyzing human questions and formulating answers to these questions; Downloadable computer program to support decision making process in the field of medicine and pharmacywhich is based on artificial intelligence
Class 42
Designinstallationupdating and rental of computer software for use in the field of medicine and pharmacy; Designinstallationupdating and implementation of computer software capable of understanding and analyzing human questions and formulating answers to these questions; Development of computer vision algorithms being a type of software development service; Design and development of computer software in the fields of artificial intelligencedeep learningdistributed computingvirtualization and machine learning; Researchdesign and development services of computer software relating to pharmaceutical products data processing by computer vision; providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence for use in machine learning at the initialbeing earlydrug discovery stage; Creating software enabling the design of synthesis paths for organic compounds taking into account the creator's preferences; Providing online non-downloadable software for the design of synthesis pathways
Publications
History of USPTO decisions and trademark events.
41 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/08/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
03/07/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/15/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/15/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/15/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/30/2022
PUBO
PUBLISHED FOR OPPOSITION
08/30/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/28/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
07/28/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/28/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
07/28/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/28/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/01/2022
GNFR
FINAL REFUSAL E-MAILED
02/01/2022
CNFR
FINAL REFUSAL WRITTEN
02/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/21/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/20/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/20/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
10/24/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/24/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/22/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/21/2021
GNRT
NON-FINAL ACTION E-MAILED
06/21/2021
CNRT
NON-FINAL ACTION WRITTEN
06/21/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/24/2020
GNSL
LETTER OF SUSPENSION E-MAILED
11/24/2020
CNSL
SUSPENSION LETTER WRITTEN
11/24/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/05/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/05/2020
RFNT
REFUSAL PROCESSED BY IB
05/29/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/08/2020
RFRR
REFUSAL PROCESSED BY MPU
05/08/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/25/2020
CNRT
NON-FINAL ACTION WRITTEN
04/24/2020
MAFR
APPLICATION FILING RECEIPT MAILED
04/21/2020
DOCK
ASSIGNED TO EXAMINER
04/17/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/17/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/16/2020
Continuous trademark protection
Get notified about every new filing that threatens MOLECULE.ONE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.